American Diabetes Association's CEO Visits Profil Institute to Acknowledge Contributions

SAN DIEGO, April 7, 2011 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today that the American Diabetes Association's CEO Larry Hausner visited Profil Institute's office to acknowledge the contributions that the company has made to support the Association at a national and local level.  

"While Profil Institute is globally known for their contributions to the scientific study of new diabetes therapies, it is often overlooked that they also are substantial supporters of the American Diabetes Association at both the national and local levels," said Hausner. "Profil Institute has proven to be a steadfast ally with its consistent, unwavering support of the Association through financial contributions and the support by its employees in activities to help raise awareness about the seriousness of diabetes."

Profil Institute sponsors the Association's two major fundraising events in San Diego each year: the Tour de Cure, a fundraising event in May with cyclists participating in routes of 10 to 100 miles, and Step Out: Walk to Fight Diabetes, the organization's largest fundraising event which takes place each year in October.  Profil Institute's CEO Dr. Marcus Hompesch served as San Diego's 2010 Corporate Chairperson for Step Out: Walk to Fight Diabetes and will do so again this year.

In conjunction with Profil Institute's sponsorship of the Tour de Cure, many of the company's employees participate in the event as a team and each individually raises money.  Profil Institute's CFO Claus Hakenesch is also San Diego's 2011 Public Relations Committee Chairperson for the event.

"As a company we do everything we can to support the American Diabetes Association as together we strive to achieve the same goal of finding better treatments and eventually a cure for diabetes," said Dr. Hompesch.  

"Profil Institute is a company that embraces the importance of being involved within its local community," said Katie Croskrey, Executive Director of American Diabetes Association's Greater San Diego Area. "Its employees are out there cycling or walking beside the very patients that participate in its clinical trials and will one day benefit from the medicines and devices that Profil Institute helps to develop to treat diabetes."

About American Diabetes Association

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

About Profil™ Institute for Clinical Research, Inc.

Profil Institute is world-renowned as a Center of Excellence for diabetes and obesity early phase clinical research.  The company's advances in early phase drug research and its specific focus on diabetes, obesity and cardio-metabolic diseases as it relates to the diabetic patient population have led Profil Institute to be the most highly regarded clinical research institute for early phase diabetes drug trials.  

To date, Profil Institute has been involved with almost every clinically promising drug category and device development in diabetes and in more than 140 clinical studies since the company's inception in 2004. Contributing to Profil Institute's success is that the company is recognized as the leader in automated glucose clamps, considered the "Gold Standard" for the evaluation of anti-diabetic drugs and devices.  The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Dusseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit www.profilinstitute.com.

SOURCE Profil